Israel-Assayag; Evelyne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Israel-Assayag; Evelyne.The latest application filed is for "method for use of homopiperazinium compounds in the treatment of cancer".

Company Profile

0.11.11

Israel-Assayag; Evelyne - Quebec CA
Israel-Assayag; Evelyne - Sainte-Foy CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for use of homopiperazinium compounds in the treatment of cancer Grant 10,507,212 - Cormier , et al. Dec	2019-12-17
Method For Use Of Homopiperazinium Compounds In The Treatment Of Cancer App 20180235978 - CORMIER; Yvon ; et al.	2018-08-23
Method for use of homopiperazinium compounds in the treatment of cancer Grant 9,949,984 - Cormier , et al. April 24, 2	2018-04-24
Preparation and method for use in the treatment of respiratory diseases Grant 9,944,610 - Israel-Assayag , et al. April 17, 2	2018-04-17
Method For Use Of Homopiperazinium Compounds In The Treatment Of Cancer App 20170173040 - CORMIER; Yvon ; et al.	2017-06-22
Preparation And Method For Use In The Treatment Of Respiratory Diseases App 20160046587 - ISRAEL-ASSAYAG; Evelyne ; et al.	2016-02-18
Nicotinic receptor agonists for the treatment of inflammatory diseases Grant 8,557,804 - Cormier , et al. October 15, 2	2013-10-15
Nicotinic receptor agonists for the treatment of inflammatory diseases Grant 8,551,983 - Cormier , et al. October 8, 2	2013-10-08
Nicotinic receptor agonists for the treatment of inflammatory diseases Grant 8,377,936 - Cormier , et al. February 19, 2	2013-02-19
Stimulation Of Innate Immunity With An Antigen From Bacterial Origin App 20120093791 - Yvon; Cormier ; et al.	2012-04-19
Nicotinic Receptor Agonists For The Treatment Of Inflammatory Diseases App 20120022049 - CORMIER; YVON ; et al.	2012-01-26
Nicotinic Receptor Agonists For The Treatment Of Inflammatory Diseases App 20110301152 - CORMIER; Yvon ; et al.	2011-12-08
Nicotinic receptor agonists for the treatment of inflammatory diseases Grant 8,039,459 - Cormier , et al. October 18, 2	2011-10-18
Nicotinic Receptor Agonists For The Treatment Of Inflammatory Diseases App 20110245270 - CORMIER; Yvon ; et al.	2011-10-06
Nicotinic Receptor Agonists For The Treatment Of Inflammatory Diseases App 20100227871 - CORMIER; Yvon ; et al.	2010-09-09
Nicotinic receptor agonists for the treatment of inflammatory diseases Grant 7,601,720 - Cormier , et al. October 13, 2	2009-10-13
Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases App 20080221085 - Cormier; Yvon ; et al.	2008-09-11
Nicotinic receptor agonists and analogues and derivatives thereof for the treatment of inflammatory diseases App 20070249622 - Cormier; Yvon ; et al.	2007-10-25
Nicotinic receptor agonists for the treatment of inflammatory diseases App 20050130990 - Cormier, Yvon ; et al.	2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.